Jeffrey P. Henderson
Publications by Year
Research Areas
COVID-19 Clinical Research Studies, SARS-CoV-2 and COVID-19 Research, Urinary Tract Infections Management, Antibiotic Resistance in Bacteria, Escherichia coli research studies
Most-Cited Works
- → Deployment of convalescent plasma for the prevention and treatment of COVID-19(2020)860 cited
- → Neutralizing Antibody and Soluble ACE2 Inhibition of a Replication-Competent VSV-SARS-CoV-2 and a Clinical Isolate of SARS-CoV-2(2020)476 cited
- → Treatment and Prevention of Urinary Tract Infection with Orally Active FimH Inhibitors(2011)311 cited
- → The siderophore yersiniabactin binds copper to protect pathogens during infection(2012)303 cited
- → Neutrophils employ the myeloperoxidase system to generate antimicrobial brominating and chlorinating oxidants during sepsis(2001)255 cited
- → Escherichia coli Biofilms Have an Organized and Complex Extracellular Matrix Structure(2013)243 cited
- → Quantitative Metabolomics Reveals an Epigenetic Blueprint for Iron Acquisition in Uropathogenic Escherichia coli(2009)226 cited
- → Association of Convalescent Plasma Therapy With Survival in Patients With Hematologic Cancers and COVID-19(2021)184 cited
- → The Heme Biosynthesis Pathway Is Essential for Plasmodium falciparum Development in Mosquito Stage but Not in Blood Stages(2014)178 cited
- → The Effect of Convalescent Plasma Therapy on Mortality Among Patients With COVID-19: Systematic Review and Meta-analysis(2021)155 cited